Ocular Therapeutix (OCUL) Receivables (2013 - 2026)
Ocular Therapeutix's Receivables came in at $30.26 million for Q2 2026, down 0.5% from $30.41 million a year earlier but up 24.3% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Receivables (2013 - 2026) Analysis & Trends
At the end of FY2025, Ocular Therapeutix's Receivables was $30.65 million, down 5.4% from FY2024.
- Receivables carries a five-year compound annual growth rate of 20.1% (FY2020 to FY2025).
- Going back by year, Receivables was $32.39 million in FY2024 (+23.7%), $26.18 million in FY2023 (+22.8%), $21.33 million in FY2022 (+0.9%) and $21.14 million in FY2021 (+72.5%).
- The five-year range for quarterly Receivables is $19.55 million (Q3 2021) to $32.39 million (Q4 2024).
- Year-over-year, Receivables has declined for three consecutive quarters, with growth averaging 5.0% over the last eight quarters.
- The fastest year-over-year change in Receivables over five years came in Q3 2021 (growth of 151.3%), and the weakest in Q1 2023 (a decline of 9.0%).
- Business Quant data shows OCUL's Receivables at $24.35 million (Q1 2026), $30.65 million (Q4 2025) and $30.77 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | 30.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.26 Mn |
| Mar 31, 2026 | 24.35 Mn |
| Dec 31, 2025 | 30.65 Mn |
| Sep 30, 2025 | 30.77 Mn |
| Jun 30, 2025 | 30.41 Mn |
| Mar 31, 2025 | 25.22 Mn |
| Dec 31, 2024 | 32.39 Mn |
| Sep 30, 2024 | 30.24 Mn |
| Jun 30, 2024 | 30.23 Mn |
| Mar 31, 2024 | 26.55 Mn |
| Dec 31, 2023 | 26.18 Mn |
| Sep 30, 2023 | 23.59 Mn |
| Jun 30, 2023 | 27.31 Mn |
| Mar 31, 2023 | 21.12 Mn |
| Dec 31, 2022 | 21.33 Mn |
| Sep 30, 2022 | 19.80 Mn |
| Jun 30, 2022 | 20.48 Mn |
| Mar 31, 2022 | 23.21 Mn |
| Dec 31, 2021 | 21.14 Mn |
| Sep 30, 2021 | 19.55 Mn |
API Access
Ocular Therapeutix Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();